116 related articles for article (PubMed ID: 29339123)
1. Identical twins with XLA requiring differing amounts of 20% subcutaneous immunoglobulin secondary to protein-losing enteropathy.
Lan J; Eshun J; Lieberman JA
J Allergy Clin Immunol Pract; 2018; 6(3):1073-1074. PubMed ID: 29339123
[No Abstract] [Full Text] [Related]
2. X-Linked Agammaglobulinaemia: Outcomes in the modern era.
Shillitoe B; Gennery A
Clin Immunol; 2017 Oct; 183():54-62. PubMed ID: 28729230
[TBL] [Abstract][Full Text] [Related]
3. Secondary hypogammaglobulinemia in Waldmann's disease treated with subcutaneous immunoglobulins.
Patuzzo G; Tinazzi E; Micheletti M; Puccetti A; Lunardi C
Eur Ann Allergy Clin Immunol; 2016 Mar; 48(2):55-7. PubMed ID: 26934740
[TBL] [Abstract][Full Text] [Related]
4. Clues to management of neonatally diagnosed BTK deficiency.
Deyà-Martínez A; Esteve-Sole A; Giner MT; Aróstegui JI; Ruiz-Ortiz E; Yagüe J; Juan M; Plaza AM; Alsina L
Pediatr Allergy Immunol; 2016 Jun; 27(4):428-30. PubMed ID: 26844683
[No Abstract] [Full Text] [Related]
5. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia.
Aghamohammadi A; Allahverdi A; Abolhassani H; Moazzami K; Alizadeh H; Gharagozlou M; Kalantari N; Sajedi V; Shafiei A; Parvaneh N; Mohammadpour M; Karimi N; Sadaghiani MS; Rezaei N
Respirology; 2010 Feb; 15(2):289-95. PubMed ID: 20051045
[TBL] [Abstract][Full Text] [Related]
6. Clinical and laboratory observation on immunoglobulin replacement therapy switching from an intravenous to a subcutaneous route in a Malaysian X-linked agammaglobulinemia patient.
Adli A; Wahab AA; Abdul Latiff AH; Ismail IH; Faizah MZ; Boekhren KB; Noh LM
Med J Malaysia; 2022 Jan; 77(1):95-97. PubMed ID: 35087003
[TBL] [Abstract][Full Text] [Related]
7. Administration of intravenous immunoglobulin in two children with hypogammaglobulinaemia due to protein losing enteropathy.
De Giacomo C; Maggiore G; Scotta MS; Ugazio AG
Clin Exp Immunol; 1985 May; 60(2):447-8. PubMed ID: 4006307
[No Abstract] [Full Text] [Related]
8. Autoimmunity and inflammation in X-linked agammaglobulinemia.
Hernandez-Trujillo VP; Scalchunes C; Cunningham-Rundles C; Ochs HD; Bonilla FA; Paris K; Yel L; Sullivan KE
J Clin Immunol; 2014 Aug; 34(6):627-32. PubMed ID: 24909997
[TBL] [Abstract][Full Text] [Related]
9. [Severe malabsorption syndrome and exudative enteropathy in hypogammaglobulinemia: complete involution with intravenous immunoglobulin substitution].
Layer P; Balzer K; Goebell H
Z Gastroenterol; 1985 Aug; 23(8):412-7. PubMed ID: 4060818
[TBL] [Abstract][Full Text] [Related]
10. Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies.
Danieli MG; Pulvirenti F; Rocchi V; Morariu R; Quinti I
Immunotherapy; 2016 Sep; 8(9):995-1002. PubMed ID: 27485073
[TBL] [Abstract][Full Text] [Related]
11. An exemplum of XLA.
Notarangelo LD; Rawlings DJ; Sullivan KE
Clin Immunol; 2008 Feb; 126(2):137-9. PubMed ID: 17974484
[No Abstract] [Full Text] [Related]
12. X-linked agammaglobulinaemia (XLA) presenting with neutropenia and Pseudomonas aeruginosa cellulitis.
MacMahon JM; Ni Chroinin M; Hourihane J; Leahy TR
Arch Dis Child; 2016 Dec; 101(12):1106. PubMed ID: 27535475
[No Abstract] [Full Text] [Related]
13. Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man.
Hendriks RW; Bredius RG; Pike-Overzet K; Staal FJ
Expert Opin Ther Targets; 2011 Aug; 15(8):1003-21. PubMed ID: 21635151
[TBL] [Abstract][Full Text] [Related]
14. X-linked agammaglobulinemia associated with B-precursor acute lymphoblastic leukemia.
Hoshino A; Okuno Y; Migita M; Ban H; Yang X; Kiyokawa N; Adachi Y; Kojima S; Ohara O; Kanegane H
J Clin Immunol; 2015 Feb; 35(2):108-11. PubMed ID: 25591849
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infection in a X-linked agammaglobulinemia adolescent: An immunological approach to treatment.
Stracuzzi M; Vanetti C; Clerici M; Zuccotti GV; Trabattoni D; Giacomet V
Pediatr Allergy Immunol; 2023 Mar; 34(3):e13921. PubMed ID: 36974650
[No Abstract] [Full Text] [Related]
16. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.
Suri D; Bhattad S; Sharma A; Gupta A; Rawat A; Sehgal S; Singh S; Gupta S
J Clin Immunol; 2017 Apr; 37(3):311-318. PubMed ID: 28321612
[TBL] [Abstract][Full Text] [Related]
17. Clinical and mutational features of X-linked agammaglobulinemia in Mexico.
García-García E; Staines-Boone AT; Vargas-Hernández A; González-Serrano ME; Carrillo-Tapia E; Mogica-Martínez D; Berrón-Ruíz L; Segura-Mendez NH; Espinosa-Rosales FJ; Yamazaki-Nakashimada MA; Santos-Argumedo L; López-Herrera G
Clin Immunol; 2016 Apr; 165():38-44. PubMed ID: 26960951
[TBL] [Abstract][Full Text] [Related]
18. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains.
Carrillo-Tapia E; García-García E; Herrera-González NE; Yamazaki-Nakashimada MA; Staines-Boone AT; Segura-Mendez NH; Scheffler-Mendoza SC; O Farrill-Romanillos P; Gonzalez-Serrano ME; Rodriguez-Alba JC; Santos-Argumedo L; Berron-Ruiz L; Sanchez-Flores A; López-Herrera G
Expert Rev Clin Immunol; 2018 Jan; 14(1):83-93. PubMed ID: 29202590
[TBL] [Abstract][Full Text] [Related]
19. Modeling primary immunodeficiency disease epidemiology and its treatment to estimate latent therapeutic demand for immunoglobulin.
Stonebraker JS; Farrugia A; Gathmann B; ; Orange JS
J Clin Immunol; 2014 Feb; 34(2):233-44. PubMed ID: 24338563
[TBL] [Abstract][Full Text] [Related]
20. Severe neutropenia in Japanese patients with x-linked agammaglobulinemia.
Kanegane H; Taneichi H; Nomura K; Futatani T; Miyawaki T
J Clin Immunol; 2005 Sep; 25(5):491-5. PubMed ID: 16160918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
